Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: J Magn Reson Imaging. 2011 Apr;33(4):808–816. doi: 10.1002/jmri.22517

Figure 2.

Figure 2

Distribution of VEGF immunopositive tissue samples among non-enhancing Grades 2 (AS2) and Grades 3 (AS3) glioma. None of the Grade 2 samples expressed VEGF while approximately half (56%) of the Grade 3 samples were VEGF positive.